Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Revlimid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Revlimid was produced by Celgene.

BMS and Celgene announce $74bn merger

BMS and Celgene announce $74bn merger

setbacks in 2018 as it sought to grow beyond its myeloma blockbuster Revlimid.

Dragonfly signs Celgene as partner for NK cell platform

Dragonfly signs Celgene as partner for NK cell platform Celgene has been signing a string of research partnerships and licensing deals in the last couple of years to diversify its portfolio and reduce its reliance on Revlimid (lenalidomide), a drug

ASH18: CAR-T and drugs give new options for multiple myeloma

ASH18: CAR-T and drugs give new options for multiple myeloma Ninlaro is already approved as a second-line therapy in combination with Celgene’s Revlimid (lenalidomide) and dexamethasone, and Takeda is also trying to move its drug into the first-line

FDA green lights BMS’ multiple myeloma combo

FDA green lights BMS’ multiple myeloma combo That particular regimen also includes corticosteroid medication dexamethasone and Celgene’s blockbuster Revlimid, which generated around $8bn in sales last year.

FDA clears first-line use for J&J’s myeloma drug Darzalex

FDA clears first-line use for J&J’s myeloma drug Darzalex Later on, additional studies of Darzalex as an add-on to regimens based on Celgene’s Revlimid (lenalidomide) and in ASCT-eligible patients could further expand the opportunity in previously-untreated

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

DNA
Why precision medicine demands precision engagement
The speed of innovation brings its own challenges, says cloud computing expert...
Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...

Infographics